Tissue-specific stem cells found in adult tissues can participate in the repair process following injury. However, adult tissues, such as articular cartilage and intervertebral disc, have low regeneration capacity, whereas fetal tissues, such as articular cartilage, show high regeneration ability. The presence of fetal stem cells in fetal cartilaginous tissues and their involvement in the regeneration of fetal cartilage is unknown. The aim of the study was to assess the chondrogenic differentiation and the plasticity of fetal cartilaginous cells. We compared the TGF-β3-induced chondrogenic differentiation of human fetal cells isolated from spine and cartilage tissues to that of human bone marrow stromal cells (BMSC). Stem cell surface markers and adipogenic and osteogenic plasticity of the two fetal cell types were also assessed. TGF-β3 stimulation of fetal cells cultured in high cell density led to the production of aggrecan, type I and II collagens, and variable levels of type X collagen. Although fetal cells showed the same pattern of surface stem cell markers as BMSCs, both type of fetal cells had lower adipogenic and osteogenic differentiation capacity than BMSCs. Fetal cells from femoral head showed higher adipogenic differentiation than fetal cells from spine. These results show that fetal cells are already differentiated cells and may be a good compromise between stem cells and adult tissue cells for a cell-based therapy.
INTRODUCTION
availability of the cells, their in vitro amplification, as well as their regeneration capacity can hamper the feasibility of these techniques (11, 16, 25) . Degeneration of cartilaginous tissues such as articular cartilage and intervertebral disc leads to disability, de-
The use of mesenchymal stem cells (MSC) opened new opportunities in treating different tissue such as creased quality of life, and higher medical costs. Cellbased therapies for cartilaginous tissue regeneration are nerve (46) , bone (47) , or for cartilaginous tissue regeneration (27, 42, 43) . MSCs can be retrieved from bone an attractive prospective as they allow potential formation of a functional tissue. Autologous cell transplanta-marrow or adipose tissue with minimally invasive procedures and can be differentiated in vitro towards chondro-tion has first been investigated for immunocompatibility reasons. Autologous chondrocyte transplantation is clin-genic, osteogenic, or adipogenic phenotypes (2, 18, 44) . Adult MSCs can only be differentiated into a limited ically applied for full-thickness cartilage lesions and autologous disc cell transplantation has also been effected number of phenotypes, whereas embryonic stem cells can virtually be differentiated into all phenotypes. Tran-in clinical trials (6, 7, 28, 33) . Although these methods achieve good clinical results, limitations regarding the sition from embryonic to adult stage involves the prolif-eration and the specialization of embryonic cells under minced in small pieces. Fetal spine units, composed of one intervertebral disc and the two adjacent vertebrae, the control of morphogens. As cells become specialized, they lose their differentiation potential. The presence of were minced in small pieces with a scalpel and put into culture in DMEM (Gibco, Switzerland) supplemented tissue-specific stem cells in various adult tissues shows that unspecialized cells remain in adult tissues (36). In with 10% fetal bovine serum (FBS) and 1% 100 mM Lglutamine (Gibco) (hereafter referred to as growth me-case of tissue injury, these cells can proliferate, differentiate, and regenerate the damaged tissue. However, the dium) at 37°C under 5% CO 2 . Femoral heads of fetal femurs were isolated, minced in small pieces with a percentage of tissue-specific stem cells has been shown to decrease with age, concomitantly to regeneration po-scalpel, and put into culture in the same conditions as for fetal spine cells. For both tissues, cells migrated from tential of these tissues (9) .
Fetal tissues, including articular cartilage, have high the minced pieces, adhered to the plastic dishes, and began to proliferate. When primary cultures reached 80% regeneration capacity, which seems inherent to fetal cells and not dependant on the local environment in the confluency, cells were detached with trypsin/EDTA and plated in T75 flask in growth medium for further cell womb (26, 31, 38) . Specific mechanisms involved in fetal cartilage regeneration are still largely unknown. Particu-expansion (passage 1). When cells reached 80% confluency, cells were detached by trypsin/EDTA, mixed to-larly, the presence of fetal stem cells in fetal cartilage and their involvement in the fetal regeneration process gether to ensure consistency, and stored in frozen vials of cells at passage 1. Thus, a dedicated and consistent is unknown. Fetal stem cells have already been isolated from fetal tissues such as bone marrow, lung, liver, cell bank was established from each biopsy as described in De Buys Roessingh et al. (12) and Quintin et al. (35) . spleen, and umbilical cord (8, 22, 23) . In addition, as fetal cells are in an intermediate stage of development be-For experiments, frozen vials were thawed and cells were expanded in monolayer and used for experiments tween undifferentiated embryonic cells and specialized adult cells, questions remain about their degree of differ-at passage 4 unless otherwise stated. Human bone marrow stromal cells (BMSC) isolated from iliac crest bone entiation and their plasticity potential, that is to say that their capacity to transdifferentiate into multiple lineages. marrow by plastic adherence selection (n = 2, aged 19 and 28 years) were kindly provided by Dr. Ivan Martin Fetal tissues offer very low immunogenic properties, which are closely dependent on the organ and gesta-from Basel University. MSCs were cultured in MSC medium consisting of α-MEM (Gibco) supplemented with tional age (15). As for fetal tissues, fetal cells showed immunogenic properties, which can be partially ex-10% FBS, 1% 100 mM L-glutamine, and freshly added 10 ng/ml fibroblast growth factor (FGF; Sigma, Switzer-plained by a low level of expression of HLA-I and the absence of HLA-II expression (1, 17, 20, 29) . As fetal land). Cells were used in experiments between passages 3 and 6. cells offer low immunogenicity, good regeneration properties, and are readily cultured in vitro, they are good FACS Analysis of Surface Markers candidates to be used for a cell-based therapy (15, 20, 34, 35) .
Fetal cells at passage 0 were thawed and cultured in either growth medium or MSC medium at passage 1. At Thus, the aim of this study was to assess the chondrogenic differentiation of fetal cells isolated from two fetal 80% confluency, cells were trypsinized and analyzed for the following surface markers: CD34, CD44, CD45-PE, cartilaginous tissues, fetal femoral head, and fetal spine. Plasticity of these cells was assessed by analyzing their CD73-PE, CD105-fluorescein, CD166-PE (all from R&D Systems, Minneapolis, MN, USA, except CD34 and stem cell surface markers and their adipogenic and osteogenic differentiation potential.
CD73 from BD Bioscience Europe, Erembodegem, Belgium). First, cells were washed in ice-cold PBS and then MATERIALS AND METHODS incubated with primary antibody in PBS with 2% FBS Cell Isolation and Culture of Fetal Cells for 30 min at 4°C. For CD34 and CD44 staining, bound antibodies were visualized by a 30-min incubation at Biopsies for cell isolation were obtained in accordance with the Ethics Committee of University Hospital 4°C with a secondary goat anti-mouse IgG-FITC labeled antibody (Invitrogen, Switzerland). After ice-cold PBS in Lausanne (Ethical Protocol 51/01). Human fetal spinal column tissues (1 cm length, n = 4: FS12w, FS13w, washing, cells were fixed with 4% PAF at 4°C for 15 min and analyzed with a CyAN ADP Analyser (DaKo-FS14w, FS16w) and human fetal femurs (n = 3, FC14w, FC16w-a, FC16w-b) were obtained from fetuses after Cytomation, Switzerland) within 24 h. Controls were performed by substituting primary antibody by isotype-voluntary interruption of pregnancy at 12-16 weeks of gestation. Biopsies were first rinsed with 1% penicillin/ PE antibody for direct staining and by omitting primary antibody for indirect staining. Percentage of positive streptomycin/PBS, cleaned from adjacent tissue, and cells was calculated by subtracting control from sample Osteogenic Differentiation with the Summit software (DaKoCytomation, Switzer-Cells were cultured in growth or MSC medium for land).
fetal cells and in MSC medium only for MSCs until confluency. Cells were then cultured in growth medium Chondrogenic Differentiation with 10 mM phosphoglycerol, 200 mg/ml ascorbic acid, Four hundred thousand fetal cells or BMSCs were and 100 nM dexamethasone for 28 days. At the end of centrifuged at 400 × g for 5 min to obtain cell pellets.
the culture period, cells were washed with PBS, fixed in Pellets were cultured in chondrogenic medium for 28 4% PAF, washed with distilled water, and stained with days with renewal of medium twice a week. Chondro-2% silver nitrate, washed with water, and then with sogenic medium was made of DMEM supplemented with dium thiosulfate. 1% of 100 mM L-glutamine, 1× insulin-transferrin-selenium (ITS), 10 mM sodium pyruvate, 40 µg/ml L-RESULTS proline, 50 µg/ml ascorbic acid, and 10 ng/ml transform-Chondrogenic Differentiation ing growth factor-3 (TGF-β3). At the end of the culture Stimulation of BMSCs, fetal spine cells, and femoral period, pellets were fixed with 4% PAF, dehydrated head cells by chondrogenic media led to the production through 70%, 80%, 94%, and 100% ethanol and xylol.
of sulfate-rich matrix as shown by the positive alcian Pellets were embedded in paraffin and 7-µm sections blue staining ( Fig. 1 ). Aggrecan was largely produced were cut.
by BMSCs, fetal spine cells, and femoral head cells Histology of Pellet (Fig. 1b ). BMSCs produced type II collagen in a specific region of the pellet, whereas fetal spine and femoral Deparafinized and rehydrated sections of pellets were head cells produced type II collagen homogenously stained for 15 min in Weigert's hematoxylin, stained for throughout the whole pellet ( Fig. 1c ). However, two fe-10 min in Alcian Blue (pH 2.5) and molybdic acid for tal spine cell donors (FS12w and FS13w) produced very 10 min, and in Sirius Red for 5 min.
low level or no type II collagen at all. BMSCs produced Immunohistochemistry of Pellet type I collagen in the whole pellet but a slightly more intense staining was observed in the type II collagen-Pellet sections were digested with hyaluronidase positive region ( Fig. 1d ). Type I collagen was strongly (Sigma, Switzerland) for aggrecan staining and with produced by three donors of fetal spine cells (FS12w, pepsin (Sigma) for type I, II, and X collagen stainings.
FS13w, FS15w) but the fourth donor (FS14w) showed After washing, sections were treated with 0.1% phenyla lower production of type I collagen. All three donors hydrazine (Merck, Switzerland), washed, and blocked in of fetal femoral head cells produced type I collagen. In PBS containing Triton X-100, FBS, and normal goat seboth types of fetal cells, a more intense staining for type rum. Sections were then incubated with primary anti-I collagen was observed at the periphery of the pellets. bodies, aggrecan (1/2000; Biosource, Belgium), type I Type X collagen was not detected in the BMSC pellets. collagen (5 µg/ml; MP Biomedicals, Switzerland), type Fetal spine cell donors were heterogenous for type X II collagen (1 µg/ml; Chemicon, Switzerland), and type collagen production. Type X collagen was detected in X collagen (1/250; Sigma, Switzerland), then washed the extracellular matrix at a low level in two fetal spine and incubated with goat anti-mouse biotinylated seconddonors (FS12w, FS14w) and it was only detected at the ary antibody (Vector Laboratories, USA). After washcellular level in the the other fetal spine cell donors ing, sections were treated with Vectastain ABC kit and (FS13w, FS15w). On the other hand, fetal femoral head DAB revelation system (Vector Laboratories). Sections cells showed a high level of type X collagen expression were counterstained with Fast Red, dehydrated, and localized at the cellular and matrix levels. Presence of mounted for microscopic observation.
enlarged chondrocytes was observed in fetal spine and Adipogenic Differentiation femoral head pellets. Cells were cultured in growth or MSC medium for Expression of Surface Markers by Fetal Spine fetal cells and MSC medium only for MSCs. At confluand Femoral Head Cells at Passage 1 ency, cells were treated with growth medium with ITS, 1 µM dexamethasone, 0.1 mM indomethacin, and 0.5
BMSCs cultured in MSC medium were positive for CD44 (99.2%), CD73 (98.8%; 99.0%), CD105 (76.9%; mM isobutylmethylxanthine. Media was changed twice a week during 21 days. Then cells were washed with 93.7%), and CD166 (99.4%) and negative for CD34 (2.9%; 5.1%), CD45 (0.2%; 0.4%) (Fig. 2, Table 1 ). Fe-PBS, fixed in 4% PAF, and stained with Oil Red and counterstained with Mayer hematoxylin. tal spine and femoral head cells cultured in growth me- dium showed the same expression pattern and were pos-production of small lipidic vacuoles (Fig. 3Aa, b, d) .
Fetal femoral head cells showed more cells positive for itive for CD44 (95.0 ± 2.8; 97.8 ± 0.3), CD73 (98.8 ± 0.8; 98.8 ± 0.2), CD105 (79.1 ± 13.7; 86.7 ± 3.8), and lipidic vacuoles and the size of lipidic vacuoles was much larger than in fetal spine cells (Fig. 3Aa, c, e ). For CD166 (99.1 ± 0.3; 98.9 ± 0.9) and negative for CD34 (3.9 ± 0.9; 3.9 ± 0.3) and CD45 (2.8 ± 1.2; 1.7 ± 1.5).
both types of fetal cells, no difference in the adipogenic differentiation was observed between growth and BMSC When cultured in MSC media, both type of fetal cells had the same level of expression of surface markers as media conditions. Similar results were obtained when fetal cells were cultured in DMEM up to passage 4 and that of in growth media (Table 1) .
then treated with adipogenic media (Fig. 3Af, g) .
Adipogenic Differentiation of Fetal Cells
Osteogenic Differentiation Fetal cells were cultured in growth or MSC media and then treated with adipogenic media. BMSCs showed Fetal cells were cultured in MSC media and then treated with osteogenic media. Fetal spine and femoral a high number of adipose vacuole-positive cells, whereas fetal spine cells in growth or BMSC media showed little head cells produced very low levels of calcium salts compared with BMSCs ( Fig. 3Oa-e) . No difference was mechanical and/or physicochemical conditions than fetal cells. Unexpectedly, type X collagen was not detected observed between fetal spine and femoral head cells. Similar results were obtained when fetal cells were cul-in BMSC pellets as previously described. Chondrogenic stimulation of MSCs is usually achieved by TGF-β1 or tured in DMEM up to passage 4 and then treated with osteogenic media (Fig. 3Of, g) .
-β3 and dexamethasone stimulation in high cell mass culture (4, 21, 24, 32, 45) . Although now debated, in this DISCUSSION model, type X collagen is sequentially induced after induction of type II collagen (4, 30, 32) . It is possible that, In this study, we first examined the TGF-β3-induced chondrogenic potential of cell populations isolated from in our model, TGF-β3 stimulation was less potent than in combination with dexamethasone to induce chondro-fetal spine and fetal femoral head. As fetal cells were isolated from cartilaginous tissues, it was expected that genic differentiation of BMSCs. On the other hand, fetal spine and femoral head cells may have been more re-they show high chondrogenic property. Alcian blue and type II collagen staining indicated chondrogenic differ-sponsive to chondrogenic stimulation as they are likely to be more differentiated than BMSCs. Longer term entiation for BMSCs and fetal cells. However, type II collagen production by BMSCs was spatially restricted chondrogenic culture and type X expression time course could give additional information on the development whereas it was homogenous in type II-positive fetal cell pellets. BMSC populations may be heterogenous for of a hypertrophic phenotype. Fetal femoral head cells expressed high level of type X collagen, which strongly type II collagen production or more sensitive to local suggests that chondrogenic medium induces hypertro-Although additional stem cell surface markers can be used to refine fetal cell population characterization, phic chondrocyte formation and raises the risk of in vivo endochondral ossification. This result could be ex-these results strengthen the fact that surface marker characterization is not enough to predict multilineage plained by the fact that cells from the secondary ossification center of the fetal femoral head may have been differentiation potential of cells. In the same way, in't Anker et al. showed that isolated fetal MSCs from bone isolated together with cells from the articular cartilage.
Induction of hypertrophy may also be due to the use marrow, liver, lung, and spleen exhibited similar surface marker expressions but different levels of adipogenic of specific in vitro culture conditions (high cell density, nonphysiological growth factor concentration), and ossi-and osteogenic differentiation (22) . We also noticed that the two sources of fetal cells had different differentiation fication of these cells should be tested in vivo using undifferentiated and differentiated cells. On the other hand, potential. Fetal femoral head cells showed a higher adipogenic differentiation potential than fetal spine cells. fetal spine cells showed very little production of type X collagen. However, cellular positive staining could be Cui et al. reported the presence of MSC-like cells in fetal articular chondrocyte population (10) . These MSC-observed in two fetal spine cell donors (FS13w, FS15w). These cells may be at an earlier stage where type X like cells could be differentiated into adipose, osteogenic, and neural cells. However, the percentage of differ-collagen has not yet been exported into the extracellular compartment, which would indicate that these cells are entiated cells was low, likely indicating that most of the cell population did not show plasticity properties. A very also directed toward endochondral ossification. Only the FS14w cells showed very low level of type X collagen.
interesting series of papers demonstrated that adult articular chondrocyte showed plastic property, and that plas-This difference may be due to the age of the donor or to a specific cell population. The identification of the ticity increased with passage and time in culture, that is to say with dedifferentiation level (3, 13, 39, 40) . How-cell types present in the fetal spinal cell population would help to answer this question. Unfortunately, spe-ever, we did not observe an increase plasticity property of fetal femoral head cells with from passage 2 to 4. cific markers for identification of these cell populations are not available. The potential clinical use of fetal spine
We did not do later passages for these cells because for potential clinical application, these cells would not nor-cells will not require in vitro differentiation and the use of growth factor-driven differentiation, possibly alleviat-mally be used after passage 4, but it cannot be excluded that higher passages of fetal femoral head cells would ing the risk of type X collagen production and endochondral ossification.
show higher osteogenic and adipogenic differentiation properties. In a second part, we examined the plasticity of fetal cells. Stem cell surface marker expression, and adipo-Further studies, such as clonal selection, are needed to determine if differentiation properties are due to genic and osteogenic differentiation by fetal cells were analyzed and compared to those of BMSCs. BMSCs can MSC-like cells or to subpopulation of fetal femoral head cells with plastic property. Interestingly, very low levels be characterized by their ability to self-renew and to differentiate into multiple lineages. A panel of surface of adipogenic differentiation were seen with fetal spine cells. These cells have been isolated from fetal spine markers has been developed to isolate and characterize BMSCs, notably the expression of CD73, CD105, and tissues and are likely to be a mixed population of fibroblastic and chondrocytic cells from fetal intervertebral CD166 and the absence of CD34 and CD45. However, the presence of specific combinations of surface markers disc annulus fibrosus, endplate, and vertebral body. This difference in plasticity level between spine and femoral is not enough to predict differentiation capacity and differentiation protocols are required (14, 19) . Fetal cells head cells may be related to the origin of the cells. Although fetal spine cells may contain fibroblastic and exhibited similar expression of the studied surface markers as BMSCs. However, fetal cells had lower adipo-chondrocytic cells from the annulus fibrosus, endplates, and vertebral body, a homogenous cell population for genic and osteogenic potential than BMSCs. Culture of MSCs requires specific culture conditions, such as the all surface markers was seen during the FACS analysis of the fetal spine cells. presence of FGF, to preserve their multilineage differentiation property whereas fetal cells are routinely cultured
In conclusion, chondrogenic stimulation by TGF-β3 of fetal cells isolated from fetal spine and femoral head in growth media, which does not contain any growth factor (5, 37, 41) . Thus, fetal cells were also cultured in led to the expression of aggrecan and type II collagen but also of type I and type X collagens. Although fetal MSC media to see if the presence of FGF had an effect on fetal cell differentiation potential. No effect of FGF cells exhibited a similar expression of stem cell markers as BMSCs, they showed low plasticity under adipogenic on adipogenic nor for osteogenic differentiation was observed, confirming the observed low plasticity of fetal and osteogenic stimulation. As fetal spine cells showed lower plasticity and lower endochondral marker expres-cells cultured in growth media. 
